Bhudeva Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 04-05-2024
- Paid Up Capital ₹ 3.73 Cr
as on 04-05-2024
- Company Age 16 Year, 11 Months
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 17.00 Cr
as on 04-05-2024
- Revenue 35.43%
(FY 2022)
- Profit 113.14%
(FY 2022)
- Ebitda -1365.58%
(FY 2022)
- Net Worth 3.65%
(FY 2022)
- Total Assets 3.98%
(FY 2022)
About Bhudeva Lifesciences
- CIN/LLPIN
U24232PB2008PLC031570
- Company No.
031570
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 Jan 2008
- Date of AGM
28 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Ludhiana, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bhudeva Lifesciences?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Dimple Gupta | Director | 08-Jan-2008 | Current |
Vikas Gupta | Director | 31-Dec-2018 | Current |
Varinder Gupta | Director | 08-Jan-2008 | Current |
Financial Performance and Corporate Structure Insights of Bhudeva Lifesciences.
Bhudeva Lifesciences Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 35.43% increase. The company also saw a substantial improvement in profitability, with a 113.14% increase in profit. The company's net worth moved up by a moderate rise of 3.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Bhudeva Lifesciences?
In 2020, Bhudeva Lifesciences had a promoter holding of 2.62% and a public holding of 97.38%. The company had 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Iol Chemicals And Pharmaceuticals LimitedActive 38 years 2 months
Vikas Gupta and Varinder Gupta are mutual person
- Mayadevi Polycot LimitedActive 27 years 9 months
Dimple Gupta, Vikas Gupta and 1 more are mutual person
- Nm Merchantiles Private LimitedActive 16 years 11 months
Dimple Gupta, Vikas Gupta and 1 more are mutual person
- Iol Speciality Chemicals LimitedActive 2 years 6 months
Vikas Gupta and Varinder Gupta are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Bank Of India Creation Date: 10 Mar 2016 | ₹8.50 Cr | Satisfied |
Bank Of India Creation Date: 30 Jun 2012 | ₹8.50 Cr | Satisfied |
How Many Employees Work at Bhudeva Lifesciences?
Unlock and access historical data on people associated with Bhudeva Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bhudeva Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bhudeva Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.